English

• 

• 1. [1] National Commission of Chinese pharmacopoeia, Pharmacopoeia of People's Republic of China, Chemical Industry Press, Beijing, 2005, pp. 265-266.[1] National Commission of Chinese pharmacopoeia, Pharmacopoeia of People's Republic of China, Chemical Industry Press, Beijing, 2005, pp. 265-266.

  2. [2] G.P. McGlacken, I.J.S. Fairlamb, 2-Pyrone natural products and mimetics: isolation, characterisation and biological activity, Nat. Prod. Rep. 22 (2005) 369-385.[2] G.P. McGlacken, I.J.S. Fairlamb, 2-Pyrone natural products and mimetics: isolation, characterisation and biological activity, Nat. Prod. Rep. 22 (2005) 369-385.

  3. [3] P.S. Steyn, F.R. Van Heerdeen, Bufadienolides of plant and animal origin, Nat. Prod. Rep. 15 (1998) 397-413.[3] P.S. Steyn, F.R. Van Heerdeen, Bufadienolides of plant and animal origin, Nat. Prod. Rep. 15 (1998) 397-413.

  4. [4] M.M. Li, S. Wu, Z. Liu, et al., Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway, Biochem. Pharmacol. 83 (2012) 1251-1260.[4] M.M. Li, S. Wu, Z. Liu, et al., Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway, Biochem. Pharmacol. 83 (2012) 1251-1260.

  5. [5] L.M.Y. Banuls, E. Urban, M. Gelbcke, et al., Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells, J. Nat. Prod. 76 (2013) 1078-1084.[5] L.M.Y. Banuls, E. Urban, M. Gelbcke, et al., Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells, J. Nat. Prod. 76 (2013) 1078-1084.

  6. [6] D.M. Zhang, J.S. Liu, L.J. Deng, et al., Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway, Carcinogenesis 34 (2013) 1331-1342.[6] D.M. Zhang, J.S. Liu, L.J. Deng, et al., Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway, Carcinogenesis 34 (2013) 1331-1342.

  7. [7] M. Ye, G.Q. Qu, H.Z. Guo, et al., Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships, J. Steroid Biochem. Mol. Biol. 91 (2004) 87-98.[7] M. Ye, G.Q. Qu, H.Z. Guo, et al., Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships, J. Steroid Biochem. Mol. Biol. 91 (2004) 87-98.

  8. [8] F.H. Qi, A.Y. Li, L. Zhao, et al., Apoptosis-inducing effect of cinobufacini on human hepatoma cell line HepG2 and its mechanism of action, Acta Pharm. Sin. 45 (2010) 318-323.[8] F.H. Qi, A.Y. Li, L. Zhao, et al., Apoptosis-inducing effect of cinobufacini on human hepatoma cell line HepG2 and its mechanism of action, Acta Pharm. Sin. 45 (2010) 318-323.

  9. [9] H.Y. Tian, L. Wang, X.Q. Zhang, et al., Bufogargarizins A and B: two novel 19-norbufadienolides with unprecedented skeletons from the venom of Bufo bufo gargarizans, Chem. Eur. J. 16 (2010) 10989-10993.[9] H.Y. Tian, L. Wang, X.Q. Zhang, et al., Bufogargarizins A and B: two novel 19-norbufadienolides with unprecedented skeletons from the venom of Bufo bufo gargarizans, Chem. Eur. J. 16 (2010) 10989-10993.

  10. [10] H.Y. Tian, L. Wang, X.Q. Zhang, et al., New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizans, Steroids 75 (2010) 884-890.[10] H.Y. Tian, L. Wang, X.Q. Zhang, et al., New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizans, Steroids 75 (2010) 884-890.

  11. [11] J.S. Liu, D.M. Zhang, Y. Li, et al., Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities, J. Med. Chem. 56 (2013) 5734-5743.[11] J.S. Liu, D.M. Zhang, Y. Li, et al., Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities, J. Med. Chem. 56 (2013) 5734-5743.

  12. [12] H.M. Gao, R. Popescu, B. Kopp, et al., Bufadienolides and their antitumor activity, Nat. Prod. Rep. 28 (2011) 953-969.[12] H.M. Gao, R. Popescu, B. Kopp, et al., Bufadienolides and their antitumor activity, Nat. Prod. Rep. 28 (2011) 953-969.

  13. [13] S.B. Wu, J.J. Su, L.H. Sun, et al., Triterpenoids and steroids from the fruits of Melia toosendan and their cytotoxic effects on two human cancer cell lines, J. Nat. Prod. 73 (2010) 1898-1906.[13] S.B. Wu, J.J. Su, L.H. Sun, et al., Triterpenoids and steroids from the fruits of Melia toosendan and their cytotoxic effects on two human cancer cell lines, J. Nat. Prod. 73 (2010) 1898-1906.

  14. [14] Y. Kamano, A. Kotake, R. Takano, et al., Conformational preference of two toad poison bufadienolides, bufarenogin and ψ-bufarenogin, Heterocycles 49 (1998) 275-279.[14] Y. Kamano, A. Kotake, R. Takano, et al., Conformational preference of two toad poison bufadienolides, bufarenogin and ψ-bufarenogin, Heterocycles 49 (1998) 275-279.

  15. [15] H.Y. Tian, X.F. Yuan, L. Jin, et al., A bufadienolide derived androgen receptor antagonist with inhibitory activities against prostate cancer cells, Chem. Biol. Interact. 207 (2014) 16-22.[15] H.Y. Tian, X.F. Yuan, L. Jin, et al., A bufadienolide derived androgen receptor antagonist with inhibitory activities against prostate cancer cells, Chem. Biol. Interact. 207 (2014) 16-22.

•